Digoxin: Pharmacology and toxicology-A review

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62690094%3A18470%2F20%3A50017107" target="_blank" >RIV/62690094:18470/20:50017107 - isvavai.cz</a>
Alternative codes found
RIV/60076658:12110/20:43901302 RIV/00179906:_____/20:10415981
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S1382668920300764" target="_blank" >https://www.sciencedirect.com/science/article/pii/S1382668920300764</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.etap.2020.103400" target="_blank" >10.1016/j.etap.2020.103400</a>

Result language
angličtina
Original language name
Digoxin: Pharmacology and toxicology-A review
Original language description
Digoxin is a cardiac glycoside used as drug in case of heart problems, including congestive heart failure, atrial fibrillation or flutter, and certain cardiac arrhythmias. It has a very narrow therapeutic window of the medication. Digoxin is toxic substance with well known cardiotoxic effect. In this work, pharmacology and toxicology of digoxin are summarized; Its pharmacokinetics, pharmacodynamics, available acute toxicity data (different species, different administration routes) are summarized in this article. Moreover, its treatment side effect and human poisonings are thoroughly discussed. Finally, appropriate therapy regimen is proposed.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30108 - Toxicology

Project
<a href="/en/project/GA17-19968S" target="_blank" >GA17-19968S: Localized Electronic Effects of Antibody Binding on NanoComposite Materials (LEEFAB)</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)